Western literature

Clcks Has Recently Partnered with Dr. Steve Brown on His Campaign to Create an Animated Koala Film

Retrieved on: 
Monday, January 23, 2023
Australian Government Film, Climate change, Endangered species, Habitat, Heat, Government, Western literature, Animation, Partnership, Research, Movement, River, Hunting, Aquaculture

Los Angeles, California--(Newsfile Corp. - January 23, 2023) - Clcks is proud to announce its partnership with Dr. Steve Brown in his campaign to bring the production of an animated Koala film to the big screen.

Key Points: 
  • Los Angeles, California--(Newsfile Corp. - January 23, 2023) - Clcks is proud to announce its partnership with Dr. Steve Brown in his campaign to bring the production of an animated Koala film to the big screen.
  • The movement focuses on the proposal of an animated koala movie, depicting lovable Koala characters taking climate action in order to undo the disastrous effects of climate change and habitat loss.
  • Worse than all this, no one seems to care, and it is simply unbearable," says Dr. Steve Brown.
  • Koala colonies around Sydney and across New South Wales may become extinct by 2050," shares Dr. Brown.

Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress

Retrieved on: 
Monday, January 9, 2023
Pyrophosphate, Orphanet Journal of Rare Diseases, PXE, Degenerative disease, Caregiver, Master of Science, Mutation, PLOS One, PLOS, Dermatology, Western literature, Safety, Precision medicine, Hospital, ABCC6, Biology, Diagnosis, Therapy, Patient, Prevalence, Human Mutation, Research, Disease, Publication, ENPP1, Natural history study, Whole genome sequencing, Genetic distance, MBA, Infant, NIH, Dietary supplement, Pharmaceutical industry

BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced that it will share topline pharmacokinetic, pharmacodynamic (PK/PD) and safety data from the ongoing Phase 1/2 clinical trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency at a virtual Investor and Analyst Event on Thursday, Feb. 16, 2023.

Key Points: 
  • We also saw promising PPi elevation in our ABCC6 Deficiency trial, with a rapid initial increase at the lowest dose of INZ-701.
  • The Company will share topline pharmacokinetic, pharmacodynamic (PK/PD) and safety data from ongoing Phase 1/2 trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency.
  • The event will also feature presentations from members of the Inozyme management team, as well as from key opinion leaders in ENPP1 Deficiency and ABCC6 Deficiency.
  • The webcast will be accessible through the Investor Relations section of Inozyme’s website under events and will be available for a limited time following the event.

Franklin Whole Home Receives Permitting Green Light from Honolulu

Retrieved on: 
Tuesday, January 10, 2023
M&M, ESS, Coal, Booth, City, LFP, FHP, AC, County, SAN, Intersolar, DPP, Western literature, Safety, Certification, Material, Renewable energy

SAN FRANCISCO, Jan. 10, 2023 /PRNewswire/ -- FranklinWH, a leading whole-home energy management solution provider, announced today that it has received the coveted Materials and Methods (M&M) Certification from the City and County of Honolulu's Department of Planning and Permitting (DPP). With the announcement, solar energy storage system (ESS) installers on the island of Oahu can now reference the Franklin Home Power M&M Certification to fast-track the standard residential permitting process and save time and money on a homeowner's rooftop solar and storage project. Now, homeowners can start to enjoy the benefits of their solar and FranklinWH system sooner without uncontrollable permitting delays.

Key Points: 
  • Now, homeowners can start to enjoy the benefits of their solar and FranklinWH system sooner without uncontrollable permitting delays.
  • Franklin Home Power (FHP) is a whole-home energy management solution that integrates solar, battery, grid, and generator power sources and manages them to optimize the safety, reliability, and efficiency of a home's energy needs.
  • With the M&M Certification, installers can now also offer the system to residents of Honolulu, the state's most populous county.
  • For more information about FranklinWH's energy management solutions, visit FranklinWH during the Intersolar conference February 14 -16, 2023 in Long Beach, CA at Booth #723.

Journal of School Health Publishes Lessons Learned by Dairy Council of California During Pandemic

Retrieved on: 
Wednesday, December 14, 2022
Education, Behavior, Health, Student, Policy, Journal of School Health, Partnership, Journal, Let, Knowledge, Kenneth Blaxter (animal nutritionist), Western literature, Dairy Council of California, COVID-19, Medicine, Milk, Agriculture

SACRAMENTO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Dairy Council of California, a leader in nutrition education and advocacy, was recently published in the esteemed Journal of School Health.

Key Points: 
  • SACRAMENTO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Dairy Council of California, a leader in nutrition education and advocacy, was recently published in the esteemed Journal of School Health.
  • The article addressed issues of nutrition security that arose during the pandemic and the solutions Dairy Council of California implemented to improve nutrition and food access in the school environment.
  • Our Let’s Eat Healthy Initiative created a platform of information and resource accessibility,” stated Dairy Council of California Officer of Partnerships and Programs Shannan Young.
  • Having our article published in a periodical as well respected as the Journal of School Health amplifies our ability to share what we learned and hopefully continue to benefit others,” stated Dairy Council of California Nutrition Science Officer Ashley Rosales.

Caribou Biosciences Reports CB-010 ANTLER Phase 1 Trial Progress

Retrieved on: 
Monday, December 12, 2022
TRAC, RNA, Western literature, Rachel Haurwitz, Patient, Fast Track, Clinical trial, Annual report, Medicine, CST, CAR, Security (finance), FDA, University of California, Food, Safety, DNA, Phenotype, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Next, PD-1, Allotransplantation, ASH, Infrared spectroscopy correlation table, Spectrochimica Acta Part B, Risk, CR, Reindeer, Alveolar soft part sarcoma, Multicenter Automatic Defibrillator Implantation Trial, Orphan drug, CRISPR/Cpf1, Research, CRISPR, Genome, Lymphatic system, University, Vaccine, Pharmaceutical industry

BERKELEY, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported new 12-month clinical data from cohort 1 in the ongoing ANTLER Phase 1 trial, which show long-term durability following a single infusion of CB-010 at the initial dose level 1 (40x106 CAR-T cells). Cohort 1 results show:

Key Points: 
  • Today at the 64th Annual ASH meeting, a trial-in-progress poster is being presented to provide details of the design and objectives of the ANTLER Phase 1 trial for CB-010 in r/r B-NHL.
  • Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases.
  • “Caribou Biosciences” and the Caribou logo are registered trademarks of Caribou Biosciences, Inc.
  • Except as required by law, Caribou undertakes no obligation to update publicly any forward-looking statements for any reason.

PenCraft Book Awards Announces ITS 2022 TOP WINNERS for Nonfiction and Christian Book Categories

Retrieved on: 
Thursday, December 15, 2022
Giant, Midnight, Seoul Music Awards, Nonfiction, Diversion Books, Publishing, Western literature, Rowman & Littlefield, Government, History, Hope, Salt and light, Medicine, Creativity, Pilgrim, Parenting, Euphoria Morning, IPSC Action Air World Shoots, Biography, Business administration, Book, Tom Freiling, Poetry, MD, Norm (mathematics), Sport, House, Battle, Strength, Grief, Hourglass, Pelican Publishing Company, Urban Christian fiction, Paramount, CARY, Drama, Music, Literature, Music therapy, Betrayal, Brandon Mull, Senior counsel, KDP, Journey, Houndstooth, Publication, Auction, Film, Medical device, Love, Autobiography, Health

HOUSTON, Dec. 15, 2022 /PRNewswire-PRWeb/ -- PenCraft Book Awards are proud to announce its 2022 winners and finalists for its 6th Annual Competition for its Nonfiction and Christian Book book categories.

Key Points: 
  • Announcement of all the 2022 Nonfiction and Christian Book Category winners for the 6th Annual PenCraft Book Awards.
  • HOUSTON, Dec. 15, 2022 /PRNewswire-PRWeb/ -- PenCraft Book Awards are proud to announce its 2022 winners and finalists for its 6th Annual Competition for its Nonfiction and Christian Book book categories.
  • The 2022 PenCraft Book Awards are given for Romance and Poetry books published between 2019 and 2022.
  • PenCraft Book Awards received hundreds of books during the 2022 competition year.

Clarivate Annual G20 Scorecard Report Reveals Insights into World's Leading Research Economies

Retrieved on: 
Thursday, November 17, 2022
Health, Invention, Web of Science, Interview, GERD, Impact, CNCI, Open access, G20, Climate, Union, Annual report, Research, United Kingdom, Access, Health care, Science, NYSE, Western literature, Policy, GDP, The arts, Institute for Scientific Information, Clarivate, Professional services, Final good, Engineering, Chemistry, Renewable energy, Management, Agriculture, Dietary supplement, EU

The report, The Annual G20 Scorecard Research Performance 2022 , has been created by the Institute for Scientific Information at Clarivate to coincide with this year's G20 Summit hosted by Bali.

Key Points: 
  • The report, The Annual G20 Scorecard Research Performance 2022 , has been created by the Institute for Scientific Information at Clarivate to coincide with this year's G20 Summit hosted by Bali.
  • Jonathan Adams, Chief Scientist at the Institute for Scientific Information at Clarivate and a co-author of the annual report said: "Our Annual G20 Scorecard provides a consistent benchmark of regional research economies for governments, funders and research institutions.
  • The research profiles within the report are selective, highlighting chosen topics of current policy interest that identify good signals of the health of the research base for each G20 member.
  • The G20 is a group of 19 leading economies, with the European Union (EU) as the additional 20thmember.

Clarivate Annual G20 Scorecard Report Reveals Insights into World's Leading Research Economies

Retrieved on: 
Thursday, November 17, 2022
Health, Invention, Web of Science, Interview, GERD, Impact, CNCI, Open access, G20, Climate, Union, Annual report, Research, United Kingdom, Access, Health care, Science, NYSE, Western literature, Policy, GDP, The arts, Institute for Scientific Information, Clarivate, Professional services, Final good, Engineering, Chemistry, Renewable energy, Management, Agriculture, Dietary supplement, EU

The report, The Annual G20 Scorecard Research Performance 2022 , has been created by the Institute for Scientific Information at Clarivate to coincide with this year's G20 Summit hosted by Bali.

Key Points: 
  • The report, The Annual G20 Scorecard Research Performance 2022 , has been created by the Institute for Scientific Information at Clarivate to coincide with this year's G20 Summit hosted by Bali.
  • Jonathan Adams, Chief Scientist at the Institute for Scientific Information at Clarivate and a co-author of the annual report said: "Our Annual G20 Scorecard provides a consistent benchmark of regional research economies for governments, funders and research institutions.
  • The research profiles within the report are selective, highlighting chosen topics of current policy interest that identify good signals of the health of the research base for each G20 member.
  • The G20 is a group of 19 leading economies, with the European Union (EU) as the additional 20thmember.

Clarivate Names World's Influential Researchers with Highly Cited Researchers 2022 List

Retrieved on: 
Tuesday, November 15, 2022
University, Science, Database, Web of Science, ESI, Population, Institute for Scientific Information, Chinese Academy of Sciences, Harvard University, Scientific misconduct, United Kingdom, Peer review, ISI, Research, NYSE, Clarivate, Western literature, Social, Retraction Watch, University of Pennsylvania, Publication, Plagiarism, Review, Police, Max Planck Society, Renewable energy, Agriculture, Pharmaceutical industry, Institute

LONDON, Nov. 15, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today revealed its 2022 list of Highly Cited Researchers™ – individuals at universities, research institutes and commercial organizations who have demonstrated a disproportionate level of significant and broad influence in their field or fields of research. The methodology draws on data from the Web of Science™ citation index, together with analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information (ISI)™ at Clarivate.

Key Points: 
  • This year Clarivate extended the qualitative analysis of the Highly Cited Researchers list, to address increasing concerns over potential misconduct (such as plagiarism, image manipulation, fake peer review).
  • With the assistance of Retraction Watch and its unparalleled database of retractions, Clarivate analysts searched for evidence of misconduct in all publications of those on the preliminary list of Highly Cited Researchers.
  • Researchers found to have committed scientific misconduct in formal proceedings conducted by a researcher's institution, a government agency, a funder or a publisher are excluded from the list of Highly Cited Researchers.
  • This is why we've expanded our qualitative analysis this year to ensure the Highly Cited Researchers list reflects genuine, community-wide research influence.

Clarivate Names World's Influential Researchers with Highly Cited Researchers 2022 List

Retrieved on: 
Tuesday, November 15, 2022
University, Science, Database, Web of Science, ESI, Population, Institute for Scientific Information, Chinese Academy of Sciences, Harvard University, Scientific misconduct, United Kingdom, Peer review, ISI, Research, NYSE, Clarivate, Western literature, Social, Retraction Watch, University of Pennsylvania, Publication, Plagiarism, Review, Police, Max Planck Society, Renewable energy, Agriculture, Pharmaceutical industry, Institute

LONDON, Nov. 15, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today revealed its 2022 list of Highly Cited Researchers™ – individuals at universities, research institutes and commercial organizations who have demonstrated a disproportionate level of significant and broad influence in their field or fields of research. The methodology draws on data from the Web of Science™ citation index, together with analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information (ISI)™ at Clarivate.

Key Points: 
  • This year Clarivate extended the qualitative analysis of the Highly Cited Researchers list, to address increasing concerns over potential misconduct (such as plagiarism, image manipulation, fake peer review).
  • With the assistance of Retraction Watch and its unparalleled database of retractions, Clarivate analysts searched for evidence of misconduct in all publications of those on the preliminary list of Highly Cited Researchers.
  • Researchers found to have committed scientific misconduct in formal proceedings conducted by a researcher's institution, a government agency, a funder or a publisher are excluded from the list of Highly Cited Researchers.
  • This is why we've expanded our qualitative analysis this year to ensure the Highly Cited Researchers list reflects genuine, community-wide research influence.